MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Nov 13, 03:55 PM (EDT)
Price
$252.92
Change
+$0.06 (+0.02%)
Capitalization
36.91B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RMD with price predictions
Nov 12, 2025

RMD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 31, 2025

RMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where RMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RMD's RSI Oscillator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where RMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RMD just turned positive on November 12, 2025. Looking at past instances where RMD's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 341 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RMD as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RMD moved below its 50-day moving average on October 09, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RMD entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.031) is normal, around the industry mean (10.242). P/E Ratio (25.881) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (1.629) is also within normal values, averaging (2.733). Dividend Yield (0.009) settles around the average of (0.016) among similar stocks. P/S Ratio (7.077) is also within normal values, averaging (111.072).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RMD is expected to report earnings to rise 5.88% to $2.70 per share on January 22

ResMed RMD Stock Earnings Reports
Q4'25
Est.
$2.70
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
The last earnings report on October 30 showed earnings per share of $2.55, beating the estimate of $2.52. With 169.78K shares outstanding, the current market capitalization sits at 36.91B.
A.I.Advisor
published Dividends

RMD paid dividends on September 18, 2025

ResMed RMD Stock Dividends
А dividend of $0.60 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 14, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USSG63.560.12
+0.19%
Xtrackers MSCI USA Selection Eq ETF
SROI33.830.04
+0.11%
Calamos Antetokounmpo Global Sus Eqs ETF
DEW60.87N/A
N/A
WisdomTree Global High Dividend ETF
BSCR19.74-0.01
-0.03%
Invesco BulletShares 2027 Corp Bd ETF
XCNY28.25-0.03
-0.10%
SPDR S&P Emerging Markets ex-China ETF

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.17%
SOLV - RMD
51%
Loosely correlated
-0.07%
NVST - RMD
44%
Loosely correlated
-0.45%
BLCO - RMD
43%
Loosely correlated
+1.03%
RVTY - RMD
40%
Loosely correlated
-0.19%
SYK - RMD
39%
Loosely correlated
+1.00%
More

Groups containing RMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.17%
Pharmaceuticals
category (378 stocks)
48%
Loosely correlated
+0.02%
Pharmaceuticals: Other
category (103 stocks)
45%
Loosely correlated
+0.03%